https://www.iconovo.se/wp-content/uploads/2023/05/Study-start-Monash-university-800-×-600-px-e1698395547620.jpg
338
800
Roger Lassing
https://www.iconovo.se/wp-content/uploads/2026/01/Breathtaking-innovation_Iconovo-300x92-2026.png
Roger Lassing2023-10-27 10:22:282024-04-16 10:05:19Iconovo’s partner Monash University has completed enrollment in a Phase I clinical trial of inhaled oxytocin in ICOoneLatest news
https://www.iconovo.se/wp-content/uploads/2023/05/Study-start-Monash-university-800-×-600-px-e1698395547620.jpg
338
800
Roger Lassing
https://www.iconovo.se/wp-content/uploads/2026/01/Breathtaking-innovation_Iconovo-300x92-2026.png
Roger Lassing2023-10-27 10:22:282024-04-16 10:05:19Iconovo’s partner Monash University has completed enrollment in a Phase I clinical trial of inhaled oxytocin in ICOone
https://www.iconovo.se/wp-content/uploads/2023/06/Affilogic-2.jpg
1080
1920
Eva Norell
https://www.iconovo.se/wp-content/uploads/2026/01/Breathtaking-innovation_Iconovo-300x92-2026.png
Eva Norell2023-06-20 11:03:032023-06-20 11:07:54Iconovo initiates feasibility study with Affilogic for development of inhalable Nanofitin®-based biotherapies
https://www.iconovo.se/wp-content/uploads/2023/06/INlagg-nyheter-.jpg
418
627
Eva Norell
https://www.iconovo.se/wp-content/uploads/2026/01/Breathtaking-innovation_Iconovo-300x92-2026.png
Eva Norell2023-06-15 14:43:322023-06-15 14:45:20Iconovo Accelerator ProgramFollow us on Linkedin
